title: Premenstrual dysphoric disorder in an adolescent female.
abstract: BACKGROUND
  A severe cyclic constellation of affective symptoms during the luteal phase of the menstrual cycle is termed premenstrual dysphoric disorder (PMDD).
  
  
  METHODS
  A 17-yr-old female was referred for evaluation of behavior changes with her menses. Parents noted behavior changes, two to three days before the onset and lasting till the end of her menses. Menarche was at 13 years. Periods were regular, with normal flow and duration and no dysmenorrhea. Psychosocial history was unremarkable. There was no history of sexual activity or abuse. Her physical exam was unremarkable. With the working diagnosis of premenstrual dysphoric syndrome she was asked to keep track of her menses on a menstrual calendar and her symptoms with a daily diary. She was treated with Fluoxetine 20 mg/day during the luteal phase of her menstrual cycle with complete resolution of her symptoms.
  
  
  CONCLUSIONS
  In PMDD the mood disturbance occurs during the late luteal phase of the menstrual cycle (approximately 1 week before the onset of menstrual bleeding), remits after the onset of menses, and can be established by a prospective daily symptom log for two consecutive cycles. The symptoms are more severe than that of premenstrual syndrome, are associated with significant functional impairment and are cyclical. Symptoms were documented prospectively as starting a few days before her menstrual bleeding and remitting at the end of it. She responded to episodic use of a selective serotonin reuptake inhibitor. This disorder needs to be better recognized, because it can be easily treated.
authors.affiliation: Division of Adolescent Medicine, Miami Children's Hospital, Miami, Florida 33155, USA. marcela.nur@mch.com
authors.forename: Marcela M
authors.initials: MM
authors.lastname: Nur
authors.forename: Mary E
authors.initials: ME
authors.lastname: Romano
authors.forename: Lorena M
authors.initials: LM
authors.lastname: Siqueira
mesh_terms: D000293:Adolescent; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects / Q000523:psychology*; D011293:Premenstrual Syndrome / Q000188:drug therapy* / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors